Genesis Healthcare, Inc.
GENN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $770 | $812 | $899 | $919 |
| % Growth | -5.1% | -9.7% | -2.2% | – |
| Cost of Goods Sold | $749 | $756 | $929 | $524 |
| Gross Profit | $21 | $55 | -$31 | $395 |
| % Margin | 2.8% | 6.8% | -3.4% | 43% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $136 |
| SG&A Expenses | $35 | $42 | $45 | $136 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $327 |
| Operating Expenses | $35 | $42 | $45 | $463 |
| Operating Income | -$14 | $13 | -$75 | -$68 |
| % Margin | -1.8% | 1.6% | -8.4% | -7.4% |
| Other Income/Exp. Net | $94 | $89 | $26 | $48 |
| Pre-Tax Income | $80 | $103 | -$49 | -$19 |
| Tax Expense | $0 | $0 | $0 | -$3 |
| Net Income | $57 | $72 | -$32 | -$8 |
| % Margin | 7.4% | 8.8% | -3.6% | -0.8% |
| EPS | 0.47 | 0.6 | -0.28 | -0.15 |
| % Growth | -21.7% | 314.3% | -86.7% | – |
| EPS Diluted | 0.33 | 0.42 | -0.28 | -0.15 |
| Weighted Avg Shares Out | 121 | 119 | 114 | 112 |
| Weighted Avg Shares Out Dil | 172 | 170 | 114 | 113 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $29 | $32 | $33 | $33 |
| Depreciation & Amortization | $41 | $63 | $68 | $24 |
| EBITDA | $150 | $197 | $52 | $38 |
| % Margin | 19.5% | 24.3% | 5.7% | 4.1% |